Bruker s Organic Q4 Revenues Dip Slightly Though Loss Turns to Profit

Feb 23, 2006

NEW YORK, Feb. 23 (GenomeWeb News) - Bruker BioSciences yesterday reported fourth quarter 2005 revenues of $80.6 million, down from $85.6 million in the fourth quarter of 2004.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Already have an account?
Login Now.

Breaking News

Bionano, Genoptix Sign Codevelopment Agreement for Hematology Diagnostics
Stanford, Fox Chase Researchers ID Relative Risk of 25 Mutations Tied to Breast and Ovarian Cancer
Interpace Signs National Coverage Agreement With Aetna for Thyroid Tests
Luminex Receives CE Mark for Aries Acute Gastroenteritis Assay
FDA Approves Abbott's Molecular CMV Assay
Sema4, GNS Healthcare Collaborate on Machine Learning for Therapy Discovery

The Scan

Bit of Uncertainty

The partially reinstated US travel ban leaves space for uncertainty for researchers, Nature News says.

Effect of Sex

Researchers find a number of traits differ by sex and could affect mouse model studies, according to Reuters.

Better Microbes

Tweaking the skin microbiome could help address some skin conditions, the New York Times reports.

This Week in PNAS

In PNAS this week: DNA methylation profiles of tumor tissue, gene dynamics in prokaryotes, and more.

Main menu